Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The Anti-Obesity Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 6.3% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.
The Snapshot of Europe Anti-Obesity Drugs Market Segmentations:
By Player:
Orexigen Therapeutics
Pfizer
Norgine Pharmaceuticals Ltd.
Vivus
FlaxoSithKline plc
Zafgen
Zafgen, Inc
Bristol-Myers Squibb
Merck & Co.
Takeda Pharmaceutical
GlaxoSmithKline
Alizyme
Shionogi USA
Rhythm Pharmaceuticals
BoehringerIngelheim GmbH
F. Hoffmann La Roche
By Type:
Prescription Drugs
OTC Drugs
By End-User:
Men
Women
By Region:
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Poland
-
Russia
-
Switzerland
-
Turkey
-
Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Iceland
-
Benelux (Belgium, Netherlands, and Luxembourg)
-
Belgium
-
Netherlands
-
Luxembourg
-
Baltic States (Estonia, Latvia, and Lithuania)
-
Estonia
-
Latvia
-
Lithuania
Table of Contents
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Anti-Obesity Drugs Market
-
1.3 Market Segment by Type
1.3.1 Europe Anti-Obesity Drugs Market Size and Growth Rate of Prescription Drugs from 2014 to 2026
1.3.2 Europe Anti-Obesity Drugs Market Size and Growth Rate of OTC Drugs from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Europe Anti-Obesity Drugs Market Size and Growth Rate of Men from 2014 to 2026
1.4.2 Europe Anti-Obesity Drugs Market Size and Growth Rate of Women from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Germany Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
1.5.2 UK Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
1.5.3 France Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Italy Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Spain Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Poland Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Russia Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Switzerland Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
1.5.9 Turkey Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Anti-Obesity Drugs Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Venders
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Anti-Obesity Drugs by Major Types
3.4.1 Market Size and Growth Rate of Prescription Drugs
3.4.2 Market Size and Growth Rate of OTC Drugs
4 Segmentation of Anti-Obesity Drugs Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Anti-Obesity Drugs by Major End-Users
4.4.1 Market Size and Growth Rate of Anti-Obesity Drugs for Men
4.4.2 Market Size and Growth Rate of Anti-Obesity Drugs for Women
5 Market Analysis by Major Regions
-
5.1 Europe Anti-Obesity Drugs Production Analysis by Top Regions
-
5.2 Europe Anti-Obesity Drugs Consumption Analysis by Top Regions
-
5.3 Europe Anti-Obesity Drugs Production, Import, Consumption and Export Analysis by Regions
-
5.3.1 Germany Anti-Obesity Drugs Production, Import, Consumption and Export Analysis
-
5.3.2 UK Anti-Obesity Drugs Production, Import, Consumption and Export Analysis
-
5.3.3 France Anti-Obesity Drugs Production, Import, Consumption and Export Analysis
-
5.3.4 Italy Anti-Obesity Drugs Production, Import, Consumption and Export Analysis
-
5.3.5 Spain Anti-Obesity Drugs Production, Import, Consumption and Export Analysis
-
5.3.6 Poland Anti-Obesity Drugs Production, Import, Consumption and Export Analysis
-
5.3.7 Russia Anti-Obesity Drugs Production, Import, Consumption and Export Analysis
-
5.3.8 Switzerland Anti-Obesity Drugs Production, Import, Consumption and Export Analysis
-
5.3.9 Turkey Anti-Obesity Drugs Production, Import, Consumption and Export Analysis
-
5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-Obesity Drugs Production, Import, Consumption and Export Analysis
-
5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Anti-Obesity Drugs Production, Import, Consumption and Export Analysis
-
5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Anti-Obesity Drugs Production, Import, Consumption and Export Analysis
6 Product Circulation of Anti-Obesity Drugs Market among Top Countries
-
6.1 Top 5 Export Countries in Anti-Obesity Drugs Market from 2014 to 2019
-
6.1.1 Top 5 Export Countries’ Export Value Analysis in Anti-Obesity Drugs Market from 2014 to 2019
-
6.1.2 Top 5 Export Countries’ Export Volume Analysis in Anti-Obesity Drugs Market from 2014 to 2019
-
6.2 Top 5 Import Countries in Anti-Obesity Drugs Market from 2014 to 2019
-
6.2.1 Top 5 Import Countries’ Import Value Analysis in Anti-Obesity Drugs Market from 2014 to 2019
-
6.2.2 Top 5 Import Countries’ Import Volume Analysis in Anti-Obesity Drugs Market from 2014 to 2019
-
6.3 Emerging Top 3 Export Countries Analysis
-
6.4 Emerging Top 3 Import Countries Analysis
7. Germany Anti-Obesity Drugs Landscape Analysis
-
7.1 Germany Anti-Obesity Drugs Landscape Analysis by Major Types
-
7.2 Germany Anti-Obesity Drugs Landscape Analysis by Major End-Users
8. UK Anti-Obesity Drugs Landscape Analysis
-
8.1 UK Anti-Obesity Drugs Landscape Analysis by Major Types
-
8.2 UK Anti-Obesity Drugs Landscape Analysis by Major End-Users
9. France Anti-Obesity Drugs Landscape Analysis
-
9.1 France Anti-Obesity Drugs Landscape Analysis by Major Types
-
9.2 France Anti-Obesity Drugs Landscape Analysis by Major End-Users
10. Italy Anti-Obesity Drugs Landscape Analysis
-
10.1 Italy Anti-Obesity Drugs Landscape Analysis by Major Types
-
10.2 Italy Anti-Obesity Drugs Landscape Analysis by Major End-Users
11. Spain Anti-Obesity Drugs Landscape Analysis
-
11.1 Spain Anti-Obesity Drugs Landscape Analysis by Major Types
-
11.2 Spain Anti-Obesity Drugs Landscape Analysis by Major End-Users
12. Poland Anti-Obesity Drugs Landscape Analysis
-
12.1 Poland Anti-Obesity Drugs Landscape Analysis by Major Types
-
12.2 Poland Anti-Obesity Drugs Landscape Analysis by Major End-Users
13. Russia Anti-Obesity Drugs Landscape Analysis
-
13.1 Russia Anti-Obesity Drugs Landscape Analysis by Major Types
-
13.2 Russia Anti-Obesity Drugs Landscape Analysis by Major End-Users
14. Switzerland Anti-Obesity Drugs Landscape Analysis
-
14.1 Switzerland Anti-Obesity Drugs Landscape Analysis by Major Types
-
14.2 Switzerland Anti-Obesity Drugs Landscape Analysis by Major End-Users
15. Turkey Anti-Obesity Drugs Landscape Analysis
-
15.1 Turkey Anti-Obesity Drugs Landscape Analysis by Major Types
-
15.2 Turkey Anti-Obesity Drugs Landscape Analysis by Major End-Users
16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-Obesity Drugs Landscape Analysis
-
16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-Obesity Drugs Landscape Analysis by Major Types
-
16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-Obesity Drugs Landscape Analysis by Major End-Users
-
16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-Obesity Drugs Landscape Analysis by Top Countries
-
16.3.1 Denmark Anti-Obesity Drugs Market Volume and Growth Rate
-
16.3.2 Finland Anti-Obesity Drugs Market Volume and Growth Rate
-
16.3.3 Norway Anti-Obesity Drugs Market Volume and Growth Rate
-
16.3.4 Sweden Anti-Obesity Drugs Market Volume and Growth Rate
-
16.3.6 Iceland Anti-Obesity Drugs Market Volume and Growth Rate
17 Benelux (Belgium, Netherlands, and Luxembourg) Anti-Obesity Drugs Landscape Analysis
-
17.1 Benelux (Belgium, Netherlands, and Luxembourg) Anti-Obesity Drugs Landscape Analysis by Major Types
-
17.2 Benelux (Belgium, Netherlands, and Luxembourg) Anti-Obesity Drugs Landscape Analysis by Major End-Users
-
17.3 Benelux (Belgium, Netherlands, and Luxembourg) Anti-Obesity Drugs Landscape Analysis by Top Countries
-
17.3.1 Belgium Anti-Obesity Drugs Market Volume and Growth Rate
-
17.3.2 Netherlands Anti-Obesity Drugs Market Volume and Growth Rate
-
17.3.3 Luxembourg Anti-Obesity Drugs Market Volume and Growth Rate
18 Baltic States (Estonia, Latvia, and Lithuania) Anti-Obesity Drugs Landscape Analysis
-
18.1 Baltic States (Estonia, Latvia, and Lithuania) Anti-Obesity Drugs Landscape Analysis by Major Types
-
18.2 Baltic States (Estonia, Latvia, and Lithuania) Anti-Obesity Drugs Landscape Analysis by Major End-Users
-
18.3 Baltic States (Estonia, Latvia, and Lithuania) Anti-Obesity Drugs Landscape Analysis by Top Countries
-
18.3.1 Estonia Anti-Obesity Drugs Market Volume and Growth Rate
-
18.3.2 Latvia Anti-Obesity Drugs Market Volume and Growth Rate
-
18.3.3 Lithuania Anti-Obesity Drugs Market Volume and Growth Rate
19 Major Players Profiles
19.1 Orexigen Therapeutics
19.1.1 Orexigen Therapeutics Company Profile and Development Status
19.1.2 Market Performance
19.1.3 Product and Service Introduction
19.2 Pfizer
19.2.1 Pfizer Company Profile and Development Status
19.2.2 Market Performance
19.2.3 Product and Service Introduction
19.3 Norgine Pharmaceuticals Ltd.
19.3.1 Norgine Pharmaceuticals Ltd. Company Profile and Development Status
19.3.2 Market Performance
19.3.3 Product and Service Introduction
19.4 Vivus
19.4.1 Vivus Company Profile and Development Status
19.4.2 Market Performance
19.4.3 Product and Service Introduction
19.5 FlaxoSithKline plc
19.5.1 FlaxoSithKline plc Company Profile and Development Status
19.5.2 Market Performance
19.5.3 Product and Service Introduction
19.6 Zafgen
19.6.1 Zafgen Company Profile and Development Status
19.6.2 Market Performance
19.6.3 Product and Service Introduction
19.7 Zafgen, Inc
19.7.1 Zafgen, Inc Company Profile and Development Status
19.7.2 Market Performance
19.7.3 Product and Service Introduction
19.8 Bristol-Myers Squibb
19.8.1 Bristol-Myers Squibb Company Profile and Development Status
19.8.2 Market Performance
19.8.3 Product and Service Introduction
19.9 Merck & Co.
19.9.1 Merck & Co. Company Profile and Development Status
19.9.2 Market Performance
19.9.3 Product and Service Introduction
19.10 Takeda Pharmaceutical
19.10.1 Takeda Pharmaceutical Company Profile and Development Status
19.10.2 Market Performance
19.10.3 Product and Service Introduction
19.11 GlaxoSmithKline
19.11.1 GlaxoSmithKline Company Profile and Development Status
19.11.2 Market Performance
19.11.3 Product and Service Introduction
19.12 Alizyme
19.12.1 Alizyme Company Profile and Development Status
19.12.2 Market Performance
19.12.3 Product and Service Introduction
19.13 Shionogi USA
19.13.1 Shionogi USA Company Profile and Development Status
19.13.2 Market Performance
19.13.3 Product and Service Introduction
19.14 Rhythm Pharmaceuticals
19.14.1 Rhythm Pharmaceuticals Company Profile and Development Status
19.14.2 Market Performance
19.14.3 Product and Service Introduction
19.15 BoehringerIngelheim GmbH
19.15.1 BoehringerIngelheim GmbH Company Profile and Development Status
19.15.2 Market Performance
19.15.3 Product and Service Introduction
19.16 F. Hoffmann La Roche
19.16.1 F. Hoffmann La Roche Company Profile and Development Status
19.16.2 Market Performance
19.16.3 Product and Service Introduction
The List of Tables and Figures (Totals 83 Figures and 153 Tables)
-
Figure Product Picture
Figure Europe Anti-Obesity Drugs Market Size and Growth Rate of Prescription Drugs from 2014 to 2026
Figure Europe Anti-Obesity Drugs Market Size and Growth Rate of OTC Drugs from 2014 to 2026
Figure Europe Anti-Obesity Drugs Market Size and Growth Rate of Men from 2014 to 2026
Figure Europe Anti-Obesity Drugs Market Size and Growth Rate of Women from 2014 to 2026
-
Figure Germany Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure UK Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure France Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Italy Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Spain Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Poland Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Russia Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Switzerland Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Turkey Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Canada Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Mexico Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Denmark Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Finland Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Norway Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Sweden Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Iceland Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Benelux (Belgium, Netherlands, and Luxembourg) Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Belgium Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Netherlands Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Luxembourg Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Baltic States (Estonia, Latvia, and Lithuania) Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Estonia Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Latvia Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Lithuania Anti-Obesity Drugs Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Anti-Obesity Drugs Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Anti-Obesity Drugs
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Anti-Obesity Drugs by Different Types from 2014 to 2026
-
Table Consumption Share of Anti-Obesity Drugs by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Prescription Drugs
Figure Market Size and Growth Rate of OTC Drugs
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Anti-Obesity Drugs by Different End-Users from 2014 to 2026
-
Table Consumption Share of Anti-Obesity Drugs by Different End-Users from 2014 to 2026
Figure Market Size and Growth Rate of Men
Figure Market Size and Growth Rate of Women
-
Table Europe Anti-Obesity Drugs Production by Major Regions
-
Table Europe Anti-Obesity Drugs Production Share by Major Regions
-
Figure Europe Anti-Obesity Drugs Production Share by Major Countries and Regions in 2014
-
Table Europe Anti-Obesity Drugs Consumption by Major Regions
-
Table Europe Anti-Obesity Drugs Consumption Share by Major Regions
-
Table Germany Anti-Obesity Drugs Production, Import, Consumption and Export Analysis
-
Table UK Anti-Obesity Drugs Production, Import, Consumption and Export Analysis
-
Table France Anti-Obesity Drugs Production, Import, Consumption and Export Analysis
-
Table Italy Anti-Obesity Drugs Production, Import, Consumption and Export Analysis
-
Table Spain Anti-Obesity Drugs Production, Import, Consumption and Export Analysis
-
Table Poland Anti-Obesity Drugs Production, Import, Consumption and Export Analysis
-
Table Russia Anti-Obesity Drugs Production, Import, Consumption and Export Analysis
-
Table Switzerland Anti-Obesity Drugs Production, Import, Consumption and Export Analysis
-
Table Turkey Anti-Obesity Drugs Production, Import, Consumption and Export Analysis
-
Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-Obesity Drugs Production, Import, Consumption and Export Analysis
-
Table Benelux (Belgium, Netherlands, and Luxembourg) Anti-Obesity Drugs Production, Import, Consumption and Export Analysis
-
Table Baltic States (Estonia, Latvia, and Lithuania) Anti-Obesity Drugs Production, Import, Consumption and Export Analysis
-
Table Top 5 Export Countries' Export Value Analysis in Anti-Obesity Drugs Market from 2014 to 2019
-
Table Top 5 Export Countries' Export Volume Analysis in Anti-Obesity Drugs Market from 2014 to 2019
-
Table Top 5 Import Countries' Import Value Analysis in Anti-Obesity Drugs Market from 2014 to 2019
-
Table Top 5 Import Countries' Import Volume Analysis in Anti-Obesity Drugs Market from 2014 to 2019
-
Figure Emerging Top 3 Export Countries Analysis
-
Figure Emerging Top 3 Import Countries Analysis
-
Table Germany Anti-Obesity Drugs Consumption by Types from 2014 to 2026
-
Table Germany Anti-Obesity Drugs Consumption Share by Types from 2014 to 2026
-
Table Germany Anti-Obesity Drugs Consumption by End-Users from 2014 to 2026
-
Table Germany Anti-Obesity Drugs Consumption Share by End-Users from 2014 to 2026
-
Table UK Anti-Obesity Drugs Consumption by Types from 2014 to 2026
-
Table UK Anti-Obesity Drugs Consumption Share by Types from 2014 to 2026
-
Table UK Anti-Obesity Drugs Consumption by End-Users from 2014 to 2026
-
Table UK Anti-Obesity Drugs Consumption Share by End-Users from 2014 to 2026
-
Table France Anti-Obesity Drugs Consumption by Types from 2014 to 2026
-
Table France Anti-Obesity Drugs Consumption Share by Types from 2014 to 2026
-
Table France Anti-Obesity Drugs Consumption by End-Users from 2014 to 2026
-
Table France Anti-Obesity Drugs Consumption Share by End-Users from 2014 to 2026
-
Table Italy Anti-Obesity Drugs Consumption by Types from 2014 to 2026
-
Table Italy Anti-Obesity Drugs Consumption Share by Types from 2014 to 2026
-
Table Italy Anti-Obesity Drugs Consumption by End-Users from 2014 to 2026
-
Table Italy Anti-Obesity Drugs Consumption Share by End-Users from 2014 to 2026
-
Table Spain Anti-Obesity Drugs Consumption by Types from 2014 to 2026
-
Table Spain Anti-Obesity Drugs Consumption Share by Types from 2014 to 2026
-
Table Spain Anti-Obesity Drugs Consumption by End-Users from 2014 to 2026
-
Table Spain Anti-Obesity Drugs Consumption Share by End-Users from 2014 to 2026
-
Table Poland Anti-Obesity Drugs Consumption by Types from 2014 to 2026
-
Table Poland Anti-Obesity Drugs Consumption Share by Types from 2014 to 2026
-
Table Poland Anti-Obesity Drugs Consumption by End-Users from 2014 to 2026
-
Table Poland Anti-Obesity Drugs Consumption Share by End-Users from 2014 to 2026
-
Table Russia Anti-Obesity Drugs Consumption by Types from 2014 to 2026
-
Table Russia Anti-Obesity Drugs Consumption Share by Types from 2014 to 2026
-
Table Russia Anti-Obesity Drugs Consumption by End-Users from 2014 to 2026
-
Table Russia Anti-Obesity Drugs Consumption Share by End-Users from 2014 to 2026
-
Table Switzerland Anti-Obesity Drugs Consumption by Types from 2014 to 2026
-
Table Switzerland Anti-Obesity Drugs Consumption Share by Types from 2014 to 2026
-
Table Switzerland Anti-Obesity Drugs Consumption by End-Users from 2014 to 2026
-
Table Switzerland Anti-Obesity Drugs Consumption Share by End-Users from 2014 to 2026
-
Table Turkey Anti-Obesity Drugs Consumption by Types from 2014 to 2026
-
Table Turkey Anti-Obesity Drugs Consumption Share by Types from 2014 to 2026
-
Table Turkey Anti-Obesity Drugs Consumption by End-Users from 2014 to 2026
-
Table Turkey Anti-Obesity Drugs Consumption Share by End-Users from 2014 to 2026
-
Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-Obesity Drugs Consumption by Types from 2014 to 2026
-
Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-Obesity Drugs Consumption Share by Types from 2014 to 2026
-
Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-Obesity Drugs Consumption by End-Users from 2014 to 2026
-
Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-Obesity Drugs Consumption Share by End-Users from 2014 to 2026
-
Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-Obesity Drugs Consumption by Major Countries from 2014 to 2026
-
Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Anti-Obesity Drugs Consumption Share by Major Countries from 2014 to 2026
-
Figure Denmark Anti-Obesity Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Finland Anti-Obesity Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Norway Anti-Obesity Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Sweden Anti-Obesity Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Iceland Anti-Obesity Drugs Market Volume and Growth Rate from 2014 to 2026
-
Table Benelux (Belgium, Netherlands, and Luxembourg) Anti-Obesity Drugs Consumption by Types from 2014 to 2026
-
Table Benelux (Belgium, Netherlands, and Luxembourg) Anti-Obesity Drugs Consumption Share by Types from 2014 to 2026
-
Table Benelux (Belgium, Netherlands, and Luxembourg) Anti-Obesity Drugs Consumption by End-Users from 2014 to 2026
-
Table Benelux (Belgium, Netherlands, and Luxembourg) Anti-Obesity Drugs Consumption Share by End-Users from 2014 to 2026
-
Table Benelux (Belgium, Netherlands, and Luxembourg) Anti-Obesity Drugs Consumption by Major Countries from 2014 to 2026
-
Table Benelux (Belgium, Netherlands, and Luxembourg) Anti-Obesity Drugs Consumption Share by Major Countries from 2014 to 2026
-
Figure Belgium Anti-Obesity Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Netherlands Anti-Obesity Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Luxembourg Anti-Obesity Drugs Market Volume and Growth Rate from 2014 to 2026
-
Table Baltic States (Estonia, Latvia, and Lithuania) Anti-Obesity Drugs Consumption by Types from 2014 to 2026
-
Table Baltic States (Estonia, Latvia, and Lithuania) Anti-Obesity Drugs Consumption Share by Types from 2014 to 2026
-
Table Baltic States (Estonia, Latvia, and Lithuania) Anti-Obesity Drugs Consumption by End-Users from 2014 to 2026
-
Table Baltic States (Estonia, Latvia, and Lithuania) Anti-Obesity Drugs Consumption Share by End-Users from 2014 to 2026
-
Table Baltic States (Estonia, Latvia, and Lithuania) Anti-Obesity Drugs Consumption by Major Countries from 2014 to 2026
-
Table Baltic States (Estonia, Latvia, and Lithuania) Anti-Obesity Drugs Consumption Share by Major Countries from 2014 to 2026
-
Figure Estonia Anti-Obesity Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Latvia Anti-Obesity Drugs Market Volume and Growth Rate from 2014 to 2026
-
Figure Lithuania Countries Anti-Obesity Drugs Market Volume and Growth Rate from 2014 to 2026
Table Company Profile and Development Status of Orexigen Therapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Orexigen Therapeutics
Figure Sales and Growth Rate Analysis of Orexigen Therapeutics
Figure Revenue and Market Share Analysis of Orexigen Therapeutics
Table Product and Service Introduction of Orexigen Therapeutics
Table Company Profile and Development Status of Pfizer
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
Figure Sales and Growth Rate Analysis of Pfizer
Figure Revenue and Market Share Analysis of Pfizer
Table Product and Service Introduction of Pfizer
Table Company Profile and Development Status of Norgine Pharmaceuticals Ltd.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Norgine Pharmaceuticals Ltd.
Figure Sales and Growth Rate Analysis of Norgine Pharmaceuticals Ltd.
Figure Revenue and Market Share Analysis of Norgine Pharmaceuticals Ltd.
Table Product and Service Introduction of Norgine Pharmaceuticals Ltd.
Table Company Profile and Development Status of Vivus
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vivus
Figure Sales and Growth Rate Analysis of Vivus
Figure Revenue and Market Share Analysis of Vivus
Table Product and Service Introduction of Vivus
Table Company Profile and Development Status of FlaxoSithKline plc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of FlaxoSithKline plc
Figure Sales and Growth Rate Analysis of FlaxoSithKline plc
Figure Revenue and Market Share Analysis of FlaxoSithKline plc
Table Product and Service Introduction of FlaxoSithKline plc
Table Company Profile and Development Status of Zafgen
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zafgen
Figure Sales and Growth Rate Analysis of Zafgen
Figure Revenue and Market Share Analysis of Zafgen
Table Product and Service Introduction of Zafgen
Table Company Profile and Development Status of Zafgen, Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zafgen, Inc
Figure Sales and Growth Rate Analysis of Zafgen, Inc
Figure Revenue and Market Share Analysis of Zafgen, Inc
Table Product and Service Introduction of Zafgen, Inc
Table Company Profile and Development Status of Bristol-Myers Squibb
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
Table Product and Service Introduction of Bristol-Myers Squibb
Table Company Profile and Development Status of Merck & Co.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co.
Figure Sales and Growth Rate Analysis of Merck & Co.
Figure Revenue and Market Share Analysis of Merck & Co.
Table Product and Service Introduction of Merck & Co.
Table Company Profile and Development Status of Takeda Pharmaceutical
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical
Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical
Figure Revenue and Market Share Analysis of Takeda Pharmaceutical
Table Product and Service Introduction of Takeda Pharmaceutical
Table Company Profile and Development Status of GlaxoSmithKline
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
Figure Revenue and Market Share Analysis of GlaxoSmithKline
Table Product and Service Introduction of GlaxoSmithKline
Table Company Profile and Development Status of Alizyme
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alizyme
Figure Sales and Growth Rate Analysis of Alizyme
Figure Revenue and Market Share Analysis of Alizyme
Table Product and Service Introduction of Alizyme
Table Company Profile and Development Status of Shionogi USA
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shionogi USA
Figure Sales and Growth Rate Analysis of Shionogi USA
Figure Revenue and Market Share Analysis of Shionogi USA
Table Product and Service Introduction of Shionogi USA
Table Company Profile and Development Status of Rhythm Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Rhythm Pharmaceuticals
Figure Sales and Growth Rate Analysis of Rhythm Pharmaceuticals
Figure Revenue and Market Share Analysis of Rhythm Pharmaceuticals
Table Product and Service Introduction of Rhythm Pharmaceuticals
Table Company Profile and Development Status of BoehringerIngelheim GmbH
Table Sales, Revenue, Sales Price and Gross Margin Analysis of BoehringerIngelheim GmbH
Figure Sales and Growth Rate Analysis of BoehringerIngelheim GmbH
Figure Revenue and Market Share Analysis of BoehringerIngelheim GmbH
Table Product and Service Introduction of BoehringerIngelheim GmbH
Table Company Profile and Development Status of F. Hoffmann La Roche
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F. Hoffmann La Roche
Figure Sales and Growth Rate Analysis of F. Hoffmann La Roche
Figure Revenue and Market Share Analysis of F. Hoffmann La Roche
Table Product and Service Introduction of F. Hoffmann La Roche
-
